Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery worldwide. Diabetes management applications, data management software & platforms, and services are used by diabetic patients and healthcare providers for remote monitoring, data analysis, and disease management. The global digital diabetes management market is driven by key factors such as increasing prevalence of diabetes, increasing penetration of digital platforms and advancement in technology.
The Coronavirus (COVID-19) virus outbreak in December 2019 has spread around the globe with the World Health Organization declaring it a pandemic. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the digital diabetes management market in 2020 and in future. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; quarantines; emergency declared; enormous slowing of the supply chain; stock market volatility; falling business confidence, and uncertainty about future etc. The whole world is experiencing severe impact on social and financial sectors, and all global industries are facing challenges during the COVID-19 pandemic. The exclusive COVID-19 Impact Analysis report by Axiom MRC explores the outbreak of COVID-19, its impact on the global and regional economies, and its implications on the digital diabetes management industry. The report studies the effect of the pandemic on the global economy by evaluating factors like consumption, GDP, business investment, key players marketing strategies, key supply and demand-side factors, epidemiological swing factors, inventory, and governmental policies & decisions.
The digital diabetes management market is analysed based on product & service, device type, end user and geography. The products & services in this report are devices, digital diabetes management apps, data management software and platforms and services. The devices segments is further bifurcated into smart glucose meters, continuous glucose monitoring systems, smart insulin pens and smart insulin pumps & smart insulin patches. Furthermore, digital diabetes management apps are classified into diabetes & blood glucose tracking apps and weight & diet management apps. Various types of the digital diabetes management market is segmented into wearable devices and handheld devices. The various end user studied in this report are self/home healthcare, hospitals & specialty diabetes clinics and academic & research institutes. On the basis of geography, the digital diabetes management market is segmented into North America, Europe, Asia-Pacific and Rest of the world.
The key competitors of this market include Medtronic PLC, F. Hoffmann-La Roche, Dexcom, Inc., Ascensia Diabetes Care Holdings Ag., Abbott Laboratories, B. Braun Melsungen AG, Tidepool, Glooko, Inc., Lifescan, Inc. (A Subsidiary of Johnson & Johnson), Agamatrix, Inc., Tandem Diabetes Care, Inc., Insulet Corporation and Dariohealth Corporation. Leading companies have invested massive capital in research & development and mergers & acquisitions activities to develop innovative products in the market
The repercussion of the COVID-19 necessitates a speculative future for economies and industries. Amongst continuous and constant developments, Axiom team of experts will bring to you timely updates about the Global Economic Impact of COVID-19.
Why to buy this report:
